Calmodulin is a critical regulator of osteoclastic differentiation, function, and survival

Journal of Cellular Biochemistry

Volumn 97, Issue 1, 2006, Pages 45-55

  Seales, Eric C ^a   Micoli, Keith J ^a   McDonald, Jay M ^a,b  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Acid transport; Calcineurin; Calcium; Calmodulin; Calmodulin dependent protein kinase II (CaMKII); Osteoclast; Osteoclastogenesis

Indexed keywords

CALCINEURIN; CALCIUM; CALMODULIN; CALMODULIN INHIBITOR; GLYCOPROTEIN GP 130; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN KINASE (CALCIUM,CALMODULIN) II; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT;

APOPTOSIS; BONE METASTASIS; BONE REMODELING; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURVIVAL; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; OSTEOARTHROPATHY; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PAGET BONE DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BONE RESORPTION; CALCIUM SIGNALING; CALMODULIN; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL SURVIVAL; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE GLYCOPROTEINS; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 30044448541     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20659     Document Type: Review

References (53)

1. Aubin JE. 1998. Bone stem cells. J Cell Biochem Suppl 30-31:73-82.
2. Bekker PJ, Gay CV. 1990. Characterization of a Ca2(+)-ATPase in osteoclast plasma membrane. J Bone Miner Res 5:557-567.
3. Benford HL, McGowan NW, Helfrich MH, Nuttall ME, Rogers MJ. 2001. Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone 28:465-473.
4. Berridge MJ, Lipp P, Bootman MD. 2000. The versatility and universality of calcium signaling. Nat Rev Mol Cell Biol 1:11-21.
5. Blair HC, Teitelbaum SL, Ghiselli R, Gluck S. 1989. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 245:855-857.
6. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423:337-342.
7. Brown OA, Sosa YE, Castro MG, Goya RG. 2000. Studies on the prolactin-releasing mechanism of histones H2A and H2B. Life Sci 66:2081-2089.
8. Burgoyne RD, Clague MJ. 2003. Calcium and calmodulin in membrane fusion. Biochim Biophys Acta 1641:137-143.
9. Chin D, Means AR. 2000. Calmodulin: A prototypical calcium sensor. Trends Cell Biol 10:322-328.
10. Day CJ, Kim MS, Stephens SR, Simcock WE, Aitken CJ, Nicholson GC, Morrison NA. 2004. Gene array identification of osteoclast genes: Differential inhibition of osteoclastogenesis by cyclosporin A and granulocyte macrophage colony stimulating factor. J Cell Biochem 91:303-315.
11. Day CJ, Kim MS, Lopez CM, Nicholson GC, Morrison NA. 2005. NFAT expression in human osteoclasts. J Cell Biochem 95:17-23.
12. Gibson RM, Schiemann WP, Prichard LB, Reno JM, Ericsson LH, Nathanson NM. 2000. Phosphorylation of human gp130 at Ser-782 adjacent to the Di-leucine internalization motif. Effects on expression and signaling. J Biol Chem 275:22574-22582.
13. Gibson RM, Laszlo GS, Nathanson NM. 2005. Calmodulin-dependent protein kinases phosphorylate gp130 at the serine-based dileucine internalization motif. Biochim Biophys Acta 1714:56-62.
14. Heymann D, Rousselle AV. 2000. gp130 cytokine family and bone cells. Cytokine 12:1455-1468.
15. Hoeflich KP, Ikura M. 2002. Calmodulin in action: Diversity in target recognition and activation mechanisms. Cell 108:739-742.
16. Hogan PG, Chen L, Nardone J, Rao A. 2003. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17:2205-2232.
17. Horgan K, Cooke E, Hallett MB, Mansel RE. 1986. Inhibition of protein kinase C mediated signal transduction by tamoxifen. Importance for antitumour activity. Biochem Pharmacol 35:4463-4465.
18. Igarashi K, Hirotani H, Woo JT, Stern PH. 2004. Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures. Bone 35:47-56.
19. Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, Kumegawa M, Kimura T, Takeya T. 2002. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 277:41147-41156.
20. Kahl CR, Means AE. 2003. Regulation of cell-cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev 24:719-736.
21. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Koji T, Urayama S, Fujiyama K, Kiriyama T, Nakashima T, Nakane PK, Nagataki S. 1997. Fas and Fas ligand interaction is necessary for human osteoblast apoptosis. J Bone Miner Res 12:1637-1646.
22. Klee CB, Ren H, Wang X. 1998. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 273:13367-13370.
23. Lee ZH, Kim HH. 2003. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun 305:211-214.
24. Manion MK, Villain M, Pan ZG, McDonald JM, Blalock JE. 2000. Cellular uptake and in situ binding of a peptide agonist for calmodulin. Biochem Biophys Res Commun 277:462-469.
25. Matsuda S, Moriguchi T, Koyasu S, Nishida E. 1998. T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J Biol Chem 273:12378-12382.
26. Means AR. 2000. Regulatory cascades involving calmodulin-dependent protein kinases. Mol Endocrinol 14:4-13.
27. Mishra JP, Mishra S, Gee K, Kumar A. 2005. Differential involvement of calmodulin-dependent protein kinase II-activated AP-1 and c-Jun N-terminal kinase-activated EGR-1 signaling pathways in tumor necrosis factor-alpha and lipopolysaccharide-induced CD44 expression in human monocytic cells. J Biol Chem 280:26825-26837.
28. Mountz JD, Wu J, Cheng J, Zhou T. 1994. Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 37:1415-1420.
29. Myers DE, Collier FM, Minkin C, Wang H, Holloway WR, Malakellis M, Nicholson GC. 1999. Expression of functional RANK on mature rat and human osteoclasts. FEBS Lett 463:295-300.
30. Plotkin LI, Weinstein RS, Parfltt AM, Roberson PK, Manolagas SC, Bellido T. 1999. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104:1363-1374.
31. Radding W, Williams JP, Hardy RW, McDonald JM, Whitaker CH, Turbat-Herrera EA, Blair HC. 1994. Calmodulin concentrated at the osteoclast ruffled border modulates acid secretion. J Cell Physiol 160: 17-28.
32. Sims NA, Jenkins BJ, Quinn JM, Nakamura A, Glatt M, Gillespie MT, Ernst M, Martin TJ. 2004. Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. J Clin Invest 113:379-389.
33. Soderling TR, Stull JT. 2001. Structure and regulation of calcium/calmodulin-dependent protein kinases. Chem Rev 101:2341-2352.
34. Su B, Jacinto E, Hibi M, Kallunki T, Karin M, Ben-Neriah Y. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77:727-736.
35. Takayanagi H. 2005. Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med 83:170-179.
36. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling-in terminal differentiation of osteoclasts. Dev Cell 3:889-901.
37. Teitelbaum SL. 2000. Bone resorption by osteoclasts. Science 289:1504-1508.
38. Teitelbaum SL. 2004. RANKing c-Jun in osteoclast development. J Clin Invest 114:463-465.
39. Turner RT, Wakley GK, Hannon KS, Bell NH. 1988. Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats. Endocrinology 122:1146-1150.
40. Wang XM, Yu SF, Yang ZP. 2000. Apoptosis of osteoclast-like cells induced by alendronate is related to Fas gene expression. Chin J Dent Res 3:26-32.
41. Weinstein RS, Chen JR, Powers CC, Stewart SA, Landes RD, Bellido T, Jilka RL, Parfitt AM, Manolagas SC. 2002. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 109:1041-1048.
42. +-ATPase and bone resorption by tamoxifen and calmodulin antagonists. Effects independent of steroid receptors. J Biol Chem 271:12488-12495.
43. Williams JP, McDonald JM, McKenna MA, Jordan SE, Radding W, Blair HC. 1997. Differential effects of tamoxifen-like compounds on osteoclastic bone degradation, H(+)-ATPase activity, calmodulin-dependent cyclic nucleotide phosphodiesterase activity, and calmodulin binding. J Cell Biochem 66:358-369.
44. Williams JP, McKenna MA, Thames AM III, McDonald JM. 2000. Tamoxifen inhibits phorbol ester stimulated osteoclastic bone resorption: An effect mediated by calmodulin. Biochem Cell Biol 78:715-723.
45. Williams JP, McKenna MA, Thames AM, III, McDonald JM. 2003a. Effects of cyclosporine on osteoclast activity: Inhibition of calcineurin activity with minimal effects on bone resorption and acid transport activity. J Bone Miner Res 18:451-457.
46. Williams JP, Thames AM III, McKenna MA, McDonald JM. 2003b. Differential effects of calmodulin and protein kinase C antagonists on bone resorption and acid transport activity. Calcif Tissue Int 73:290-296.
47. Wu X, McKenna MA, Feng X, Nagy TR, McDonald JM. 2003. Osteoclast apoptosis: The role of Fas in vivo and in vitro. Endocrinology 144:5545-5555.
48. Wu X, Ahn EY, McKenna MA, Yeo H, McDonald JM. 2005a. Fas binding to calmodulin regulates apoptosis in osteoclasts. J Biol Chem 280:29964-29970.
49. Wu X, Pan G, McKenna MA, Zayzafoon M, Xiong WC, McDonald JM. 2005b. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts. J Bone Miner Res 20:107-116.
50. Yip KH, Zheng MH, Steer JH, Giardina TM, Han R, Lo SZ, Bakker AJ, Cassady AI, Joyce DA, Xu J. 2005. Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production. J Bone Miner Res 20:1462-1471.
51. Zayzafoon M, Fulzele K, McDonald JM. 2005. Calmodulin and calmodulin-dependent kinase IIalpha regulate osteoblast differentiation by controlling c-fos expression. J Biol Chem 280:7049-7059.
52. Zhang L, Feng X, McDonald JM. 2003. The role of calmodulin in the regulation of osteoclastogenesis. Endocrinology 144:4536-4543.
53. Zhang L, McKenna MA, Said-Al-Naief N, Wu X, Feng X, McDonald JM. 2005. Osteoclastogenesis: The role of calcium and calmodulin. Grit Rev Eukaryot Gene Expr 15:1-13.